Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Fubon Financial (2881.TW)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date	Stock Price (NT$)	Price Target (NT$)	Rating
2022-02-28	NaN	83.90	Buy
2022-06-15	61.80	62.20	Neutral
2022-09-28	50.10	54.40	Neutral
2023-01-16	59.40	72.00	Buy
2023-03-17	55.50	69.20	Buy
2023-05-18	61.10	72.80	Buy
2023-08-25	62.80	73.60	Buy
2023-11-20	63.50	72.00	Buy
2023-12-13	62.90	73.00	Buy
2024-03-25	69.00	78.00	Buy
2024-06-05	74.00	84.20	Buy
2024-09-04	90.50	-	No Rating
2024-09-20	90.80	102.70	Buy
2025-05-23	81.50	82.00	Neutral

Disclosures

This company/entity is, or within the past 12 months has been, a client of UBS Securities LLC, and non-investment banking securities-related services are being, or have been, provided.
This company/entity is, or within the past 12 months has been, a client of UBS Securities LLC, and non-securities services are being, or have been, provided.
Within the past 12 months, UBS has received compensation for products and services other than investment banking services from this company/entity.
UBS holds a long or short position of 0.5% or more of the listed shares of this company.

Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.